Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460232) titled 'FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease' on March 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Mayo Clinic

Condition: Cushing Disease Pituitary Adenoma

Intervention: Drug: Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: April 2026

Target Sample Size: 50

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07460232

Pub...